Congrats to Mike for his work @NatMentHealth about which psychosis patient subgroups may benefit most from treatment with muscarinic receptor agonist Cobenfy: https://t.co/vVU1s4aClL
#schizophrenia#precisionpsychiatry
We had a fantastic time with our visitors from Helsinki last week: Satu and Matias Palva.
Thanks for their exciting presentations to the lab and fruit full discussions of future endeavors!
Congratulations to Norman and Arghya, who have been awarded with this years "Neuroscience Chair's Award for Postdoctoral Research" @TuftsMedSchool honoring their work in the recent discovery of a prefrontal transthalamic role in decision making under uncertainty. #Tupaia, #Nature
But combining a drug that enhances a neurochemical feature broadly with targeted neurostimulation that augments these benefits to specific circuits could. Pairing such an approach with appropriately-timed behavioral therapy may allow for the brain to be re-wired for recovery.
Huiwen and Navi are going to present their amazing work at #Cosyne2025. Go check out their work if you get the chance:
"A direct link between prefrontal E/I balance and executive dysfunction in schizophrenia" and "A prefrontal to amygdala pathway for adaptive sleep interruption"